Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

Zied LandoulsiSawssan BenromdhanMouna Ben DjebaraMariem DamakHamza DallaliRym KefiSonia AbdelhakAmina Gargouri-BerrechidChokri MhiriRiadh Goudier

Published in: BMC medical genetics (2017)

The G2019S mutation frequency in our cohort was similar to that reported in previous studies. Comparing to Taqman assay and Sanger sequencing, KASP was shown to be a reliable, time and cost effective genotyping assay for routine G2019S screening in genetic testing laboratories.

Keyphrases

high throughput
single cell
clinical practice
genome wide
gene expression
dna methylation